Dan-dan Zhou
NHC Key Laboratory Of Biotechnology For Microbial Drugs, Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
hIMB1636-LDM, a novel anti-TROP2 ADC, exerts potent antitumor efficacy in pancreatic cancer via direct cytotoxicity and immune activation.
Journal: Biochemical pharmacology
Published: March 20, 2026
Preclinical characterization of IBD0333, a novel CD24×4-1BB bispecific antibody with tumor-dependent agonistic activity for cancer immunotherapy.
Journal: Antibody therapeutics
Published: January 12, 2026
Ag3In3(SeO3)3(SO4)F4: A Sulfate Selenite Nonlinear Optical Material with a Wide Bandgap.
Journal: Inorganic chemistry
Published: September 30, 2025
h3B7A-LDM, a novel anti-mesothelin antibody-drug conjugate with the potential to induce antitumor immunity, shows potent efficacy against solid tumors.
Journal: Journal of pharmaceutical analysis
Published: February 06, 2025
hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer.
Journal: Journal of medicinal chemistry
Published: October 26, 2023
A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers.
Journal: NPJ precision oncology
Published: August 30, 2023
Elucidating the development, characterization, and antitumor potential of a novel humanized antibody against Trop2.
Journal: International journal of biological macromolecules
Published: February 07, 2023
Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Journal: Military Medical Research
Published: April 26, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026